FDA Says No Cardio Risk with Olmesartan in Diabetes Patients
After completing a safety review, the US Food and Drug Administration (FDA) found no evidence that the blood pressure medication olmesartan increases cardiovascular risks in people with diabetes.
Heart Drug Linked to Celiac Symptoms
A popular medication that can help with high blood pressure may also cause severe gastrointestinal problems such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities. But why?